Abstract:e13092 Background: Breast cancer is the most common malignant tumor in the female population worldwide and has become the disease with the highest cancer-related mortality. Among the molecular subtypes of breast cancer, triple-negative breast cancer accounts for only 15% of primary malignancies, but due to its increasing recurrence, metastasis, and mortality, we need to find new therapeutic targets to address this phenomenon. Analysis from the field of metabolism found that the level of glycolysis in triple-negative breast cancer was significantly higher than that in other cancers. Glycolysis is a common malignant phenotype of cancer, namely the famous Warburg effect. LDHA is the last metabolic enzyme in the glycolytic pathway, and its expression is increased in triple-negative breast cancer. Lactate is the final product of glycolysis, which converts pyruvate to lactate and NADH to NAD+ under the catalysis of LDHA. The acidic tumor microenvironment formed by the accumulation of lactate will not only affect the progression of tumors and the therapeutic effect of anticancer drugs, but also inhibit the function of immune cells. Lactic acid groups can bind to histones and non-histone proteins to produce a new post-translational modification, lactylation. Methods: Breast cancer cells were infected with lentivirus vectors overexpressing or knocking down LDHA, and cell proliferation and cytotoxicity assay, transwell assay and Lactic Acid Content Assay were performed. To further explore the presence of lactylation of LDHA, immunoprecipitation experiments were performed and the modification sites were mutated to examine the enzymatic activity and function of LDHA. Results: In triple negative breast cancer with strong glycolytic metabolic phenotype, altering LDHA level can affect the biological function of breast cancer cells. Secondly, RNA-seq sequencing results showed that LDHA can affect the protein and transcription levels of MEST and CSTA. Finally, the lactylation of histones was also significantly changed after LDHA dysregulated. Reduced levels of LDHA were accompanied by reduced levels of MEST, CSTA, and histone lactylation. In addition, LDHA itself also has lactic acid modification, and mutations in the modification sites can change the enzymatic activity and function of LDHA. Conclusions: The regulatory axis of LDHA-lactate-lactylation has important value and function in the occurrence and development of breast cancer. LDHA regulates the function of some genes by lactate-induced lactylation of histones. In addition, the lactylation of LDHA can alter the enzyme activity, which may be a new therapeutic target for breast cancer.

P53/lactate Dehydrogenase A Axis Negatively Regulates Aerobic Glycolysis and Tumor Progression in Breast Cancer Expressing Wild-Type P53.

Tumor Suppressor P53 Negatively Regulates Glycolysis Stimulated by Hypoxia Through Its Target RRAD

Lactate-induced lactylation circularly regulates glucose metabolism enzymes in breast cancer.

Upregulation Of Lactate Dehydrogenase A By 14-3-3 Zeta Leads To Increased Glycolysis Critical For Breast Cancer Initiation And Progression

The Fundamental Role of the P53 Pathway in Tumor Metabolism and Its Implication in Tumor Therapy

Suppressed Expression of Ldhb Promotes Pancreatic Cancer Progression Via Inducing Glycolytic Phenotype

The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.

Wild-Type P53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation.

The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer

Abstract LB-25: CD147 Promotes Reprogramming of Glucose Metabolism and Cell Proliferation in HCC Cells by Inhibiting P53-Dependent Signaling Pathway

Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.

CD147 Promotes Reprogramming of Glucose Metabolism and Cell Proliferation in HCC Cells by Inhibiting the P53-Dependent Signaling Pathway

Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells.

Elucidating the kinetic and thermodynamic insight into regulation of glycolysis by lactate dehydrogenase and its impact on tricarboxylic acid cycle and oxidative phosphorylation in cancer cells

Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation

Oncogenic lncRNA LINC00973 promotes Warburg effect by enhancing LDHA enzyme activity

Inhibition of LDHA suppresses tumor progression in prostate cancer

p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP

Lactate induces tumor progression via LAR motif-dependent Yin-Yang 1 degradation

Lactate Dehydrogenase A is Overexpressed in Pancreatic Cancer and Promotes the Growth of Pancreatic Cancer Cells

Effect of Linc-00475 Regulation of p53 on Glycolysis and Survival in Gastric Cancer